2026 ICD-10-CM Diagnosis Code T41.0X5SAdverse effect of inhaled anesthetics, sequela

ICD-10-CM CodesS00–T88T36-T50T41

ICD-10-CM T41.0X5S
CMSSource: CMS FY 2026 ICD-10-CM dataset · Effective Oct 1, 2025 – Sep 30, 2026

T41.0X5S is a billable ICD-10-CM diagnosis code for adverse effect of inhaled anesthetics, sequela. The 7th character S marks it as a sequela code, which reports a problem that remains after the original condition has resolved. It is valid on HIPAA claims for fiscal year 2026 (October 1, 2025 through September 30, 2026) and groups to MS-DRG 922 through 923. The code is not accepted as a principal diagnosis by the Medicare Code Editor and exempt from POA reporting. In AHRQ's Clinical Classifications Software (CCSR), this diagnosis falls under Mental and substance use disorders; sequela; and Poisoning/toxic effect/adverse effects/underdosing, sequela.

Code Identity

ICD-10-CM Code
T41.0X5S
Billable Status
Yes — Valid for Submission
Code Describes
Adverse effect of inhaled anesthetics, sequela
Short Description
Adverse effect of inhaled anesthetics, sequela
Same as the full description in the CMS dataset.
Parent Code
Adverse effect of inhaled anesthetics

Code Classification

ChapterS00–T88Injury, poisoning and certain other consequences of external causes
SectionT36-T50Poisoning by, adverse effect of and underdosing of drugs, medicaments and biological substances
CategoryT41Poisoning by, adverse effect of and underdosing of anesthetics and therapeutic gases
This CodeT41.0X5SAdverse effect of inhaled anesthetics, sequela

Code EditsBilling

Medicare Code Editor checks that affect claim validity for T41.0X5S.

There are selected codes that describe a circumstance which influences an individual's health status but not a current illness or injury, or codes that are not specific manifestations but may be due to an underlying cause. These codes are considered unacceptable as a principal diagnosis.

Present on Admission (POA)Billing

T41.0X5S is exempt from POA reporting on inpatient claims to general acute care hospitals. Review other POA exempt codes.

Approximate SynonymsGuidance

Alternate terms and clinical phrases that map to this code.

  • Acute megaloblastic anemia
  • Acute megaloblastic anemia caused by nitrous oxide
  • Adverse reaction to inhaled anesthetic with ether structure
  • Adverse reaction to nitrous oxide
  • Chemical pneumonitis caused by anesthesia
  • Desflurane adverse reaction
  • Drug-induced apnea
  • Drug-induced hepatitis
  • Enflurane adverse reaction
  • Enflurane hepatitis
  • Enflurane poisoning
  • Ether apnea
  • Halothane adverse reaction
  • Halothane hepatitis
  • Halothane shakes
  • Inhalational anesthetics adverse reaction
  • Isoflurane adverse reaction
  • Megaloblastic anemia caused by drugs
  • Poisoning by halothane
  • Trichloroethylene adverse reaction

Coding GuidelinesGuidance

When coding an adverse effect of a drug that has been correctly prescribed and properly administered, assign the appropriate code for the nature of the adverse effect followed by the appropriate code for the adverse effect of the drug.

The appropriate 7th character is to be added to each code from block Poisoning by, adverse effect of and underdosing of anesthetics and therapeutic gases (T41). Use the following options for the applicable episode of care:

  • A - initial encounter
  • D - subsequent encounter
  • S - sequela

Source: ICD-10-CM Official Guidelines for Coding and Reporting, FY 2026, published by CMS and the National Center for Health Statistics.

Clinical ClassificationClinical

AHRQ’s CCSR groups this code into broader clinical categories.

CCSR MBD034
Mental and substance use disorders; sequela
Default principal diagnosis: inpatient No · outpatient Yes
CCSR INJ075
Poisoning/toxic effect/adverse effects/underdosing, sequela
Default principal diagnosis: inpatient No · outpatient No

Clinical InformationClinical

  • Enflurane

    an extremely stable inhalation anesthetic that allows rapid adjustments of anesthesia depth with little change in pulse or respiratory rate.
  • Halothane

    a nonflammable, halogenated, hydrocarbon anesthetic that provides relatively rapid induction with little or no excitement. analgesia may not be adequate. nitrous oxide is often given concomitantly. because halothane may not produce sufficient muscle relaxation, supplemental neuromuscular blocking agents may be required. (from ama drug evaluations annual, 1994, p178)
  • Isoflurane

    a stable, non-explosive inhalation anesthetic, relatively free from significant side effects.
  • Methoxyflurane

    an inhalation anesthetic. currently, methoxyflurane is rarely used for surgical, obstetric, or dental anesthesia. if so employed, it should be administered with nitrous oxide to achieve a relatively light level of anesthesia, and a neuromuscular blocking agent given concurrently to obtain the desired degree of muscular relaxation. (from ama drug evaluations annual, 1994, p180)

Table of Drugs and ChemicalsClinical

Substances in the Table of Drugs and Chemicals that reference this code family. Always confirm in the Tabular List before coding.

SubstanceAccidentalSelf-harmAssaultUndeter­minedAdverse
Effect
Under­dosing
Divinyl etherT41.0X1T41.0X2T41.0X3T41.0X4T41.0X5T41.0X6
EnfluraneT41.0X1T41.0X2T41.0X3T41.0X4T41.0X5T41.0X6
Ether (vapor)T41.0X1T41.0X2T41.0X3T41.0X4T41.0X5T41.0X6
Ether (vapor)::anestheticT41.0X1T41.0X2T41.0X3T41.0X4T41.0X5T41.0X6
Ether (vapor)::divinylT41.0X1T41.0X2T41.0X3T41.0X4T41.0X5T41.0X6
Ether (vapor)::ethyl (medicinal)T41.0X1T41.0X2T41.0X3T41.0X4T41.0X5T41.0X6
Ether (vapor)::ethyl (medicinal)::nonmedicinalT41.0X1T41.0X2T41.0X3T41.0X4T41.0X5T41.0X6
Ether (vapor)::petroleumT41.0X1T41.0X2T41.0X3T41.0X4T41.0X5T41.0X6
Ether (vapor)::solventT41.0X1T41.0X2T41.0X3T41.0X4T41.0X5T41.0X6
FluothaneT41.0X1T41.0X2T41.0X3T41.0X4T41.0X5T41.0X6
FluroxeneT41.0X1T41.0X2T41.0X3T41.0X4T41.0X5T41.0X6
HalothaneT41.0X1T41.0X2T41.0X3T41.0X4T41.0X5T41.0X6
IsofluraneT41.0X1T41.0X2T41.0X3T41.0X4T41.0X5T41.0X6
Laughing gasT41.0X1T41.0X2T41.0X3T41.0X4T41.0X5T41.0X6
MethoxyfluraneT41.0X1T41.0X2T41.0X3T41.0X4T41.0X5T41.0X6
Trifluoroethyl vinyl etherT41.0X1T41.0X2T41.0X3T41.0X4T41.0X5T41.0X6
TrileneT41.0X1T41.0X2T41.0X3T41.0X4T41.0X5T41.0X6
Vinesthene, vinetheneT41.0X1T41.0X2T41.0X3T41.0X4T41.0X5T41.0X6

Patient EducationClinical

Drug Reactions

Most of the time, medicines make our lives better. They reduce aches and pains, fight infections, and control problems such as high blood pressure or diabetes. But medicines can also cause unwanted reactions, such as drug interactions, side effects, and allergies.

The full article covers:

  • What is a drug interaction?
  • What are side effects?
  • What are drug allergies?
  • How can I stay safe when taking medicines?

Read the full article at MedlinePlus

Courtesy of MedlinePlus, a service of the U.S. National Library of Medicine.

Convert T41.0X5S to ICD-9-CMHistory

The closest ICD-9-CM equivalents under the General Equivalence Mappings.

ICD-9-CM
909.5 Lte efct advrs efct drug
ApproximateCombination The match is approximate, and more than one code can be needed to describe the source diagnosis. Confirm with contextual judgment.
ICD-9-CM
E938.2 Adv eff gas anesthet NEC
ApproximateCombination The match is approximate, and more than one code can be needed to describe the source diagnosis. Confirm with contextual judgment.

Code HistoryHistory

FY 2016AddedAdded to the ICD-10-CM code setEffective October 1, 2015, the first year of ICD-10-CM.
FY 2017–2025No changes
FY 2026CurrentCurrent code set, no changesEffective October 1, 2025 through September 30, 2026.

Questions About T41.0X5SOverview

Is T41.0X5S (Adverse effect of inhaled anesthetics) a billable code?

Yes. This is a billable ICD-10-CM code, specific enough to report adverse effect of inhaled anesthetics, sequela on HIPAA-covered claims from October 1, 2025 through September 30, 2026.

What does the 7th character S in T41.0X5S mean?

The final character S makes this a sequela code: it reports a lingering problem that remains after the adverse effect of inhaled anesthetics itself has resolved, not the original event.

What MS-DRG does T41.0X5S group to?

On inpatient claims, adverse effect of inhaled anesthetics, sequela maps to MS-DRG 922, 923, with relative weights from 1.0177 to 1.7494 depending on complications. Higher weights mean higher Medicare reimbursement.

Can T41.0X5S be a principal diagnosis?

No. The Medicare Code Editor rejects this code as a principal diagnosis because adverse effect of inhaled anesthetics, sequela describes a circumstance that influences health status rather than a current illness. Report it as a secondary diagnosis.

Is T41.0X5S exempt from POA reporting?

Yes. CMS lists this code among those exempt from present on admission reporting, so hospitals do not assign a POA indicator for adverse effect of inhaled anesthetics, sequela on inpatient claims.

Footnotes

[1] Not chronic - A diagnosis code that does not fit the criteria for chronic condition (duration, ongoing medical treatment, and limitations) is considered not chronic. Some codes designated as not chronic are acute conditions. Other diagnosis codes that indicate a possible chronic condition, but for which the duration of the illness is not specified in the code description (i.e., we do not know the condition has lasted 12 months or longer) also are considered not chronic.